Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mila Kessiova"'
Autor:
Almira Georgieva, Marián Kukan, Elina Tzvetanova, Mila Kessiova, Albena Alexandrova, Margarita Kirkova, Lubomir Petrov
Publikováno v:
Hepatology Research. 38:393-401
Aim: Previous studies have shown that proteasome inhibitors exerted protective effects against ischemia/reperfusion injury (IRI) of brain, heart, kidney and intestine. The aim of the present study was to investigate: (i) whether the proteasome inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31675984aed709b05d9ab3bb0f0271a4
https://doi.org/10.1111/j.1872-034x.2007.00270.x
https://doi.org/10.1111/j.1872-034x.2007.00270.x
Publikováno v:
Acta Biologica Hungarica. 58:359-367
The in vitro effects of alloxan and the product of its reduction dialuric acid (alone or in combination with copper ions) on lipid peroxidation, carbonyl content, GSH level and antioxidant enzyme activities in rat liver and kidney have been studied.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22306ce8cb3e61e6af5f50154625993e
https://doi.org/10.1556/abiol.58.2007.4.3
https://doi.org/10.1556/abiol.58.2007.4.3
Autor:
Elina Tzvetanova, Marián Kukan, Lubomir Petrov, Albena Alexandrova, Mila Kessiova, Almira Georgieva, Margarita Kirkova
Publikováno v:
Journal of biochemical and molecular toxicology. 22(5)
Copper toxicity is associated with formation of reactive oxygen species, which are capable to oxidize proteins. The selective removal of the latter by the 20S proteasome is considered an essential part of the cell antioxidant defense system. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f45774a1a1b1e78ccbe7a2c6063dac94
https://pubmed.ncbi.nlm.nih.gov/18972400
https://pubmed.ncbi.nlm.nih.gov/18972400
Publikováno v:
Pharmacological reports : PR. 58(6)
The in vitro effects of arachidonyl-2-chloroethylamide (ACEA; a selective CB(1)-receptor agonist) and N-piperidin-l-yl)-5-(4-chlorophenyl)-1-(2,4-cochlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A; a selective CB(1)-receptor antagonist) on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a26cbadf82db9c42f1386ebf7888e690
https://pubmed.ncbi.nlm.nih.gov/17220544
https://pubmed.ncbi.nlm.nih.gov/17220544
Autor:
Elina, Tsvetanova, Mila, Kessiova, Albena, Alexandrova, Lubomir, Petrov, Margarita, Kirkova, Simeon, Todorov
Publikováno v:
Pharmacological reports : PR. 58(6)
In vivo experiments were conducted to study the effects of N-(piperidin-l-yl)-5-(4-chlorophenyl)-1-(2,4-cochlo-rophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A; a potent and selective CB(1)-receptor antagonist) and ara-chidonyl-2-chloroethylam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f0206d4225c06593ad3ecab0dbed152e
https://pubmed.ncbi.nlm.nih.gov/17220545
https://pubmed.ncbi.nlm.nih.gov/17220545